PFE vs SDGR · P/E 20, rev $62.58B vs rev $207.5M
Pfizer Inc (PFE) versus Schrodinger Inc (SDGR) — a side-by-side from cached financials, not a winner call.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Schrodinger Inc (SDGR) is a health information services company listed on NASDAQ.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Latest reported SDGR revenue for 2024-12-31 was $207.5M. Net income was -$187.1M. Revenue was down 4.2% from 2023-12-31 to 2024-12-31. SDGR currently screens at market cap $1.16B.
PFE currently screens at market cap $147.73B and trailing P/E 19.8. SDGR currently screens at market cap $1.16B.
Not investment advice. Open the PFE and SDGR stock pages for the full models.
Not investment advice.